Factors associated with vertebral fracture risk in patients with primary hyperparathyroidism

European Journal of Endocrinology

Volumn 171, Issue 3, 2014, Pages 399-406

  Eller Vainicher, Cristina ^a   Battista, Claudia ^b   Guarnieri, Vito ^b   Muscarella, Silvana ^b,c   Palmieri, Serena ^a   Salcuni, Antonio Stefano ^b   Guglielmi, Giuseppe ^b   Corbetta, Sabrina ^a   Minisola, Salvatore ^d   Spada, Anna ^a   Hendy, Geoffrey N ^e   Cole, David E C ^f   Chiodini, Iacopo ^a   Scillitani, Alfredo ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^c FATEBENEFRATELLI HOSPITAL   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e MCGILL UNIVERSITY   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALCIUM PHOSPHATE; CALCIUM SENSING RECEPTOR; DNA; G PROTEIN COUPLED RECEPTOR; GENOMIC DNA;

ADULT; ALLELE; ARTICLE; BODY MASS; BONE DENSITY; BONE RADIOGRAPHY; CALCIUM BLOOD LEVEL; CALCIUM METABOLISM; CAUCASIAN; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPENDENT VARIABLE; DISEASE ASSOCIATION; DNA POLYMORPHISM; DNA SEQUENCE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; GENE AMPLIFICATION; GENOTYPE; HEREDITY; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MORPHOMETRICS; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; OUTPATIENT; POLYMERASE CHAIN REACTION; PREVALENCE; PRIMARY HYPERPARATHYROIDISM; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SPINE FRACTURE; AGE; AGED; BLOOD; INJURY; LUMBAR VERTEBRA; MIDDLE AGED; PHYSIOLOGY; RADIOGRAPHY; URINE; VERY ELDERLY; YOUNG ADULT;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BONE DENSITY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERPARATHYROIDISM, PRIMARY; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; RISK FACTORS; SPINAL FRACTURES; YOUNG ADULT;

EID: 84907189525     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-14-0343     Document Type: Article

References (33)

1. Melton LJ III. Epidemiology of primary hyperparathyroidism. Journal of Bone and Mineral Research 1995 6 25-30. (doi:10.1002/jbmr. 5650061409)
2. Lundgren E, Rastad J, Thurfjell E, Akerstrom G & Ljunghall S. Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women. Surgery 1997 121 287-294. (doi:10.1016/S0039- 6060(97)90357-3)
3. Mosekilde L. Primary hyperparathyroidism and the skeleton. Clinical Endocrinology 2008 69 1-19. (doi:10.1111/j.1365-2265.2007.03162.x)
4. Larsson K, Ljunghall S, Krusemo UB, Naessen T, Lindh E & Persson I. The risk of hip fractures in patients with primary hyperparathyroidism: a population-based cohort study with a follow-up of 19 years. Journal of Internal Medicine 1993 234 585-593. (doi:10.1111/j.1365-2796.1993. tb01017.x)
5. Khosla S, Melton LJ III, Wermers RA, Crowson CS, O'Fallon WM & Riggs BL. Primary hyperparathyroidism and the risk of fracture: a population-based study. Journal of Bone and Mineral Research 1994 14 1700-1707. (doi:10.1359/jbmr.1999.14.10.1700)
6. Vestergaard P, Mollerup CL, Frøkjaer VG, Christiansen P, Blichert- Toft M & Mosekilde L. Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism. BMJ 2000 321 598-602. (doi:10.1136/bmj.321.7261.598)
7. Dempster DW, ParisienM, Silverberg SJ, Liang XG, Schnitzer M, Shen V, Shane E, Kimmel DB, Recker R, Lindsay R et al. On the mechanism of cancellous bone preservation in postmenopausal women with mild primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism 1999 840 1562-1566. (doi:1210/jcem.84.5.5652)
8. De Geronimo S, Romagnoli E, Diacinti D, D'Erasmo E & Minisola S. The risk of fractures in postmenopausal women with primary hyperparathyroidism. European Journal of Endocrinology 2006 155 415-420. (doi:10.1530/eje.1.02225)
9. Vignali E, Viccica G, Diacinti D, Cetani F, Cianferotti L, Ambrogini E, Banti C, Del Fiacco R, Bilezikian JP, Pinchera A et al. Morphometric vertebral fractures in postmenopausal women with primary hyperparathyroidism. Journal of Clinical Endocrinology andMetabolism 2009 94 2306-2312. (doi:10.1210/jc.2008-2006)
10. Bilezikian JP. Bone strength in primary hyperparathyroidism. Osteoporosis International 2003; 14: S113-S115. (doi:10.1007/s00198-003-1482-4)
11. Eller-Vainicher C, Filopanti M, Palmieri S, Ulivieri FM, Morelli V, Zhukouskaya VV, Cairoli E, Pino R, Naccarato A, Verga U et al. Bone quality, as measured by trabecular bone score, in patients with primary hyperparathyroidism. European Journal of Endocrinology 2013 169 155-162. (doi:10.1530/EJE-13-0305)
12. Romagnoli E, Cipriani C, Nofroni I, Castro C, Angelozzi M, Scarpiello A, Pepe J, Diacinti D, Piemonte S, Carnevale V et al. "Trabecular bone score" (TBS): an indirect measure of bone micro-architecture in postmenopausal patients with primary hyperparathyroidism. Bone 2012 53 154-159. (doi:10.1016/j.bone.2012.11.041)
13. Silva BC, Boutroy S, Zhang C, McMahon DJ, Zhou B, Wang J, Udesky J, Cremers S, Sarquis M, Guo XD et al. Trabecular bone score (TBS) - a novel method to evaluate bone microarchitectural texture in patients with primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism 2013 98 1963-1970. (doi:10.1210/jc.2012-4255)
14. Eastell R, Arnold A, Brandi ML, Brown EM, D'Amour P, Hanley DA, Rao DS, Rubin MR, Goltzman D, Silverberg SJ et al. Diagnosis of asymptomatic primary hyperparathyroidism: Proceedings of the Third International Workshop. Journal of Clinical Endocrinology and Metabolism 2009 94 340-350. (doi:10.1210/jc.2008-1758)
15. Brown EM, Pollak M & Hebert SC. The extracellular calcium-sensing receptor: its role in health and disease. Annual Review of Medicine 1998 49 15-29. (doi:10.1146/annurev.med.49.1.15)
16. Hendy GN, D'Souza-Li L, Yang B, Canaff L & Cole DEC. Mutations of the calcium-sensing receptor (CASR) in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia. Human Mutation 2000 16 281-296. (doi:10.1002/1098-1004(200010)16:4!281::AID-HUMU1O3.0.CO;2-A)
17. Heath H III, Odelberg S, Jackson CE, Teh BT, Hayward N, Larsson C, Buist NR, Krapcho KJ, Hung BC, Capuano IV et al. Clustered inactivating mutations and benign polymorphisms of the calcium receptor gene in familial benign hypocalciuric hypercalcemia suggest receptor functional domains. Journal of Clinical Endocrinology and Metabolism 1996 81 1312-1317. (doi:10.1210/jcem.81.4.8636323)
18. Scillitani A, Guarnieri V, Battista C, De Geronimo S, Muscarella LA, Chiodini I, Cignarelli M, Minisola S, Bertoldo F, Francucci CM et al. Primary hyperparathyroidism and the presence of kidney stones are associated with different haplotypes of the calcium-sensing receptor. Journal of Clinical Endocrinology and Metabolism 2007 92 277-283. (doi:10.1210/jc.2006-0857)
19. Vezzoli G, Tanini A, Ferrucci L, Soldati L, Bianchin C, Franceschelli F, Malentacchi C, Porfirio B, Adamo D, Terranegra A et al. Influence of calcium-sensing receptor gene on urinary calcium excretion in stoneforming patients. Journal of the American Society of Nephrology 2002 13 2517-2523. (doi:10.1097/01.ASN.0000030077.72157.D2)
20. Corbetta S, Eller-Vainicher C, Filopanti M, Saeli P, Vezzoli G, Arcidiacono T, Loli P, Syren ML, Soldati L, Beck-Peccoz P et al. R990G polymorphism of the calcium-sensing receptor and renal calcium excretion in patients with primary hyperparathyroidism. European Journal of Endocrinology 2006 155 687-692. (doi:10.1530/eje.1.02286)
21. Cole DE, Peltekova VD, Rubin LA, Hawker GA, Vieth R, Liew CC, Hwang DM, Evrovski J & Hendy GN. A986S polymorphism of the calcium-sensing receptor and circulating calcium concentrations. Lancet 1999 353 112-115. (doi:10.1016/S0140-6736(98)06434-4)
22. Cole DE, Vieth R, Trang HM, Wong BY, Hendy GN & Rubin LA. Association between total serum calcium and the A986S polymorphism of the calcium-sensing receptor gene. Molecular Genetics and Metabolism 2001 72 168-174. (doi:10.1006/mgme.2000.3126)
23. Scillitani A, Guarnieri V, De Geronimo S, Muscarella LA, Battista C, D'AgrumaL, Bertoldo F, FlorioC, Minisola S, HendyGNet al. Blood ionized calcium is associated with clustered polymorphisms in the carboxylterminal tail of the calcium-sensing receptor. Journal of Clinical Endocrinology andMetabolism 2004 89 5634-5638. (doi:10.1210/jc.2004-0129)
24. Christensen SE, Nissen PH, Vestergaard P, Heickendorff L, Rejnmark L, Brixen K & Mosekilde L. Skeletal consequences of familial hypocalciuric hypercalcemia vs primary hyperparathyroidism. Clinical Endocrinology 2009 71 798-807. (doi:10.1111/j.1365-2265.2009.03557.x)
25. Isaksen T, Nielsen CS, Christensen SE, Nissen PH, Heickendorff L & Mosekilde L. Forearm bone mineral density in familial hypocalciuric hypercalcemia and primary hyperparathyroidism: a comparative study. Calcified Tissue International 2011 89 285-294. (doi:10.1007/s00223- 011-9517-x)
26. Brown EM. Role of the calcium-sensing receptor in extracellular calcium homeostasis. Best Practice & Research. Clinical Endocrinology & Metabolism 2013 27 333-343. (doi:10.1016/j.beem.2013.02.006)
27. Marie PJ. The calcium-sensing receptor in bone cells: a potential therapeutic target in osteoporosis. Bone 2010 46 571-576. (doi:10.1016/j.bone.2009.07.082)
28. Eller-Vainicher C, Chiodini I, Battista C, Viti R, Mascia ML, Massironi S, Peracchi M, D'Agruma L, Minisola S, Corbetta S et al. Sporadic and MEN1-related primary hyperparathyroidism: differences in clinical expression and severity. Journal of Bone and Mineral Research 2009 24 1404-1410. (doi:10.1359/jbmr.090304)
29. Carnevale V, Pipino M, Antonacci M, Checchia C, D'Alessandro V, Errico M, Greco A & Varriale A. Prevalence of hypercalcemia in hospitalised patients: effects of "correction" for serum albumin values. Journal of Endocrinological Investigation 2005 28 15-27. (doi:10.1007/BF03347215)
30. Genant HK, Wu CY, van Knijk C & Nevitt M. Vertebral fracture assessment using a semi-quantitative technique. Journal of Bone and Mineral Research 1993 8 1137-1148. (doi:10.1002/jbmr. 5650080915)
31. Eller-Vainicher C, Cairoli E, Zhukouskaya VV, Morelli V, Palmieri S, Scillitani A, Beck-Peccoz P & Chiodini I. Prevalence of subclinical contributors to low bone mineral density and/or fragility fracture. European Journal of Endocrinology 2013 169 225-237. (doi:10.1530/EJE-13-0102)
32. Naylor K & Eastell R. Bone turnover markers: use in osteoporosis. Nature Reviews. Rheumatology 2012 8 379-389. (doi:10.1038/nrrheum.2012.86)
33. Gupta M, Cheung C-L, Hsu Y-H, Demissie S, Cupples LA, Kiel DP & Karasik D. Identification of homogeneous genetic architecture of multiple genetically correlated traits by block clustering of genomewide associations. Journal of Bone and Mineral Research 2011 26 1261-1271. (doi:10.1002/jbmr.333)